Cargando…
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection
According to the World Health Organization, approximately 150 million people worldwide are chronic carriers of hepatitis C virus (HCV). HCV infection can evolve into cirrhosis of the liver and its complications, which are ultimately responsible for more than 350,000 deaths every year. Antiviral ther...
Autores principales: | Gentile, Ivan, Buonomo, Antonio Riccardo, Zappulo, Emanuela, Minei, Giuseppina, Morisco, Filomena, Borrelli, Francesco, Coppola, Nicola, Borgia, Guglielmo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079632/ https://www.ncbi.nlm.nih.gov/pubmed/25061308 http://dx.doi.org/10.2147/TCRM.S66731 |
Ejemplares similares
-
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C
por: Gentile, Ivan, et al.
Publicado: (2013) -
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2019) -
Current evidence on the management of hepatitis B in pregnancy
por: Maraolo, Alberto Enrico, et al.
Publicado: (2018) -
The role of curcumin in liver diseases
por: Buonomo, Antonio Riccardo, et al.
Publicado: (2018) -
Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection
por: Pinchera, Biagio, et al.
Publicado: (2023)